Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Lockett

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Nature Genetics|August 10, 2004
In situ analyses of genome instability in breast cancerKoei Chin, Carlos Ortiz de Solorzano, David Knowles, et al.
The Journal of Experimental Medicine|March 6, 2013
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiationLue Dai, Kristy B Lidie, Qian Chen, et al.
International Journal of Molecular Sciences|July 2, 2021
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune MicroenvironmentChristopher L McGinity, Erika M Palmieri, Veena Somasundaram, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancerDebashree Basudhar, Sharon A Glynn, Madison Greer, et al.
Redox Biology|May 7, 2026
NOS2 and COX2 impact the spatial landscape of CD8<sup>+</sup> T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survivalLisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
British Journal of Cancer|July 10, 2020
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer modelYiannis Philippou, Hanna T Sjoberg, Emma Murphy, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER <sup>-</sup> Breast Tumors that Lead to Poor OutcomeRobert Ys Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Ys Cheng, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Nature Genetics|August 10, 2004
In situ analyses of genome instability in breast cancerKoei Chin, Carlos Ortiz de Solorzano, David Knowles, et al.
The Journal of Experimental Medicine|March 6, 2013
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiationLue Dai, Kristy B Lidie, Qian Chen, et al.
International Journal of Molecular Sciences|July 2, 2021
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune MicroenvironmentChristopher L McGinity, Erika M Palmieri, Veena Somasundaram, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancerDebashree Basudhar, Sharon A Glynn, Madison Greer, et al.
Redox Biology|May 7, 2026
NOS2 and COX2 impact the spatial landscape of CD8<sup>+</sup> T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survivalLisa A Ridnour, Robert Ys Cheng, William F Heinz, et al.
British Journal of Cancer|July 10, 2020
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer modelYiannis Philippou, Hanna T Sjoberg, Emma Murphy, et al.
Blood|August 26, 2016
Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiencyDouglas B Kuhns, Danielle L Fink, Uimook Choi, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER <sup>-</sup> Breast Tumors that Lead to Poor OutcomeRobert Ys Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast CancerLisa A Ridnour, William F Heinz, Robert Ys Cheng, et al.
Cell Death & Disease|May 11, 2023
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER<sup>-</sup> breast tumors that lead to poor outcomeRobert Y S Cheng, Lisa A Ridnour, Adelaide L Wink, et al.
Pageof 6